Corporate ActionJul 16, 2026, 04:14 PM
Entera Bio Shareholders Approve 150% Increase in Authorized Shares
AI Summary
Entera Bio Ltd. shareholders approved a significant amendment to the company's Articles of Association, increasing the number of authorized Ordinary Shares from 140,010,000 to 350,000,000. Additionally, shareholders approved an increase of 2,500,000 Ordinary Shares to the 2018 Equity Incentive Plan. The Annual Meeting also saw the election of three Class III directors and the approval of various compensation-related proposals for directors and the CEO.
Key Highlights
- Authorized Ordinary Shares increased from 140,010,000 to 350,000,000.
- 2018 Equity Incentive Plan shares increased by 2,500,000 Ordinary Shares.
- Sean Ellis, Steven D. Rubin, and Geno H. Germano elected as Class III directors.
- Amended compensation terms for non-executive directors were approved.
- Share-based compensation for Steven D. Rubin and Geno J. Germano was approved.
- One-time compensation grants for Sean Ellis and CEO Miranda Toledano were approved.
Price Impact
More from ENTX